| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $8.6M | +13.6% |
| SG&A Expense | $5.8M | +16.1% |
| Operating Income | -$14.4M | -14.6% |
| Net Income | -$14.3M | -15.3% |
| EPS (Basic) | -$1.31 | -15.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.2M | -27.8% |
| Short-term Investments | $18.0M | -6.3% |
| Current Assets | $58.7M | -19.2% |
| Total Assets | $58.8M | -20.4% |
| Current Liabilities | $2.8M | +20.3% |
| Total Liabilities | $2.8M | +17.6% |
| Stockholders' Equity | $56.0M | -21.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.8M | -20.5% |
| Capital Expenditures | $28K | +79.7% |
| Investing Cash Flow | $179K | +100.9% |
| Financing Cash Flow | -$2.2M | -103.4% |
| Free Cash Flow | -$12.8M | -20.6% |